Predictive Biotech

Our parent company Predictive Technology Group have made several updates and progress reports on its Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test (Assurance AB) intended for laboratories and healthcare workers at the point-of-care in the U.S. Please follow the link below for additional details.



https://lnkd.in/gtvmR4d

Predictive is using a genomic database analytics approach to help with patient selection, to increase efficiencies and quality of clinical trials, and to shorten time to market for Atrin’s drug candidates. Atrin’s pipeline also includes preclinical drug candidates in development for glioblastoma and hematological disorders that are being advanced towards IND enabling studies.


https://lnkd.in/gZGwjrK

Our parent company, Predictive Technology Group, will be collaborating with ATRIN pharmaceuticals to improve cancer patient outcomes with targeted therapies.

Predictive Technology Group » Predictive Technology Group and Atrin Pharmaceuticals Announce Molecular Diagnostic Oncology Development Collaboration Global Site/Page Description

Congratulations to Dr. Ward, Rakesh, and Dr, Albertsen for receiving the 2019 Endometriosis Special Interest Group Prize Paper Award in "Best in Clinical / Population Science"!

PREDICTIVE LABORATORIES TEAM LED BY LABORATORY DIRECTOR KENNETH WARD, M.D. RECEIVES 2019 ENDOMETRIOSIS SPECIAL INTEREST GROUP PRIZE PAPER AWARD PREDICTIVE LABORATORIES TEAM LED BY LABORATORY DIRECTOR KENNETH WARD, M.D. RECEIVES 2019 ENDOMETRIOSIS SPECIAL INTEREST GROUP PRIZE PAPER AWARD Research presented by Dr. Hans Albertsen of Juneau Biosciences advancing knowledge of the genetic factors contributing to endometriosis receives award at th...